This Speaker Series on ‘Practical Considerations for Integrating CAR T into Clinical Practice for Lymphoma’ was a sponsored symposium with international speakers Professor Laurie Sehn and Professor Sattva Neelapu, the objective of which was to provide Australian physicians with an update on recent advances in patient selection and optimisation for CAR T-cell therapy along with strategies for optimising the outcomes of CAR T-cell therapy in relapsed or refractory large B-cell lymphoma.
Please login below to download this issue (PDF)